Tardive dyskinesia is a side effect of long-term use of antipsychotics. Until now, there has been 4 major hypotheses suggested for the etiology of TD and recommended pharmacological treatments related to these hypotheses. The best approaches for the treatment of TD are assessed by following the 4 major hypotheses and the related pharmacological treatments.egységes, osztatlanáltalános orvosango
The use of second-generation antipsychotics has not eliminated tardive dyskinesia (TD), and the prev...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
Tardive dyskinesia (TD) is a common and potentially irreversible side effect of dopamine blocking ag...
Tardive dyskinesia is a potentially fatal side effect of antipsychotics. In the classic form is char...
Tardive dyskinesia (TD) consists of involuntary movements of the tongue, lips, face, trunk, and extr...
Tardive dyskinesia (TD) is a disorder characterized by involuntary movements, typically of the orofa...
Tardive dyskinesia (TD) has long been thought to be a generally irreversible consequence of...
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most frequently affects...
Tardive dyskinesia is a late side-effect of neuroleptic therapy which occurs in up to a fifth of chr...
Objective: Tardive dyskinesia (TD) is the principal adverse effect of long-term treatment with conve...
Tardive dyskinesia (TD) is an involuntary movement disorder associated with agents that block dopami...
Tardive dyskinesia (TD) is an iatrogenic human hyperkinetic movement disorder associated with chroni...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
Background: Tardive dyskinesia (TD) is a movement disorder that causes involuntary, repetitive body ...
The use of second-generation antipsychotics has not eliminated tardive dyskinesia (TD), and the prev...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
Tardive dyskinesia (TD) is a common and potentially irreversible side effect of dopamine blocking ag...
Tardive dyskinesia is a potentially fatal side effect of antipsychotics. In the classic form is char...
Tardive dyskinesia (TD) consists of involuntary movements of the tongue, lips, face, trunk, and extr...
Tardive dyskinesia (TD) is a disorder characterized by involuntary movements, typically of the orofa...
Tardive dyskinesia (TD) has long been thought to be a generally irreversible consequence of...
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most frequently affects...
Tardive dyskinesia is a late side-effect of neuroleptic therapy which occurs in up to a fifth of chr...
Objective: Tardive dyskinesia (TD) is the principal adverse effect of long-term treatment with conve...
Tardive dyskinesia (TD) is an involuntary movement disorder associated with agents that block dopami...
Tardive dyskinesia (TD) is an iatrogenic human hyperkinetic movement disorder associated with chroni...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
Background: Tardive dyskinesia (TD) is a movement disorder that causes involuntary, repetitive body ...
The use of second-generation antipsychotics has not eliminated tardive dyskinesia (TD), and the prev...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...
All antipsychotics, including the atypical antipsychotics (AAPs), may cause tardive dyskinesia (TD),...